Alere Connected Health Ltd.

www.alere.co.il

Formerly Inverness Israel

Multinational Corporation

Ceased to Operate Q2/2016

TECH VERTICALS

Diagnostics, Digital Health, Healthtech, Life Sciences, Medical Devices, MedTech

General Data

Sector	Medical Devices
Established	1996
Number of Employees	50
Reg. Number:	abCDe

DESCRIPTION

Alere Connected Health's main objective is to develop reliable and easy to use diagnostic test kits for infectious diseases. Alere develops, manufactures and markets sophisticated, yet user friendly, self contained In-Vitro diagnostic kits. The company's line includes a comprehensive line of tests for AIDS, Hepatitis, Chlamydia, TORCH and H. pylori.

TECHNOLOGY

Cardiology, women’s health, infectious disease, oncology

Products and Phases

Product	Phase
Determine	FDA Approved
Alere Determine™ HIV-1/2 Ag/ Ab Combo empowers healthcare providers, at the point-of-care, to screen for HIV earlier than ever before. It is the first rapid test that screens for both HIV 1/2 antibodies and the HIV -1 p24 antigen- giving you the ability to screen for HIV days after infection, in its most infectious stage. Read More By combining antigen and antibodies in HIV screening, Alere Determine Combo give you a new advantage in the fight against AIDS – the ability to identify HIV sooner than conventional rapid tests, which rely solely on the presence of HIV 1/2 antibodies. In the race to prevent the spread of HIV, the Alere Determine Combo Test gives you and your patients a head-start at the point-of-care

	TARGET MARKETS
	Medical laboratories, Hospital Laboratories, Physicians and Chemists, Departments of Health and State Organizations.

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
		Alere Inc.
2A96093E-207A-E111-AC59-00155D32A403	R&D Center	Alere Connected Health Ltd.	Alere Inc.	Ceased

REMARKS

Date	Remark
01/01/1996	Inverness Medical Innovations (of Massachusetts, US) acquired Orgenics Ltd. and turned it into its local R&D center. In 2010 Inverness changed its name to Alere.

CONTACT INFO

Expand / Collapse All

Main Address: Yavne, Israel

Address	37 Shidlovsky St., North Industrial Zone
POB	360
City	Yavne
Country	Israel
Zip	70650

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Ms. Rosanne Tzuk	Director of Development
Ms. Ariela Ben-Zvi	Research and Development, Project Manager

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe	R&D grant

Last Updated:	abCDe
IVC Number:	abCDe